Endoscopic ultrasound guided-gastroenterostomy is the best choice in the treatment of gastric outlet obstruction

First of all, I would like to congratulate Vilas-Boas <i>et al</i> on an interesting publication. In this letter the authors write about very interesting topics in the management of patients with malignant gastric outlet obstruction (GOO). GOO developed in up to 20% of patients with advanced hepatopancreatobiliary disease both in benign and malignant form. For this reason, the issue is very current. I fully agree with Vilas-Boas <i>et al</i> that technical aspect of the procedures (surgeon's view) often differs from the patient's view (regarding such factors as cancer-related survival, overall survival, body mass composition, nutritional biomarkers, chemotherapy tolerance and patient-reported quality of life). The mentioned factors should be taken into account when interpreting the effectiveness of treatment modalities for malignant GOO (mGOO), which should be also considered in the future studies in this subject. In my opinion, all above mentioned factors could be summarized in one term: "Improving quality of life of patients with mGOO".

Authors

Institutions

Publication Details

Journal
World Journal of Gastrointestinal Endoscopy
Published
2024-12-11
DOI
https://doi.org/10.4253/wjge.v16.i12.691
Primary Topic
Esophageal and GI Pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Endoscopic ultrasound guided-gastroenterostomy is the best choice in the treatment of gastric outlet obstruction

Mateusz Jagielski
World Journal of Gastrointestinal Endoscopy
Esophageal and GI Pathology
article

Endoscopic ultrasound guided-gastroenterostomy is the best choice in the treatment of gastric outlet obstruction

Mateusz Jagielski
article en

Abstract

First of all, I would like to congratulate Vilas-Boas <i>et al</i> on an interesting publication. In this letter the authors write about very interesting topics in the management of patients with malignant gastric outlet obstruction (GOO). GOO developed in up to 20% of patients with advanced hepatopancreatobiliary disease both in benign and malignant form. For this reason, the issue is very current. I fully agree with Vilas-Boas <i>et al</i> that technical aspect of the procedures (surgeon's view) often differs from the patient's view (regarding such factors as cancer-related survival, overall survival, body mass composition, nutritional biomarkers, chemotherapy tolerance and patient-reported quality of life). The mentioned factors should be taken into account when interpreting the effectiveness of treatment modalities for malignant GOO (mGOO), which should be also considered in the future studies in this subject. In my opinion, all above mentioned factors could be summarized in one term: "Improving quality of life of patients with mGOO".

World Journal of Gastrointestinal EndoscopyVol. 16(12)
Nicolaus Copernicus University (PL)
Zero hunger
Openalex Percentile: Top 58%
Esophageal and GI Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.